Other Operating Expenses - GlaxoSmithKline PLC (NYSE:GSK) - Alpha Spread
G

GlaxoSmithKline PLC
NYSE:GSK

Watchlist Manager
GlaxoSmithKline PLC
NYSE:GSK
Watchlist
Price: 38.82 USD 1.17% Market Closed
Market Cap: 79.2B USD
Have any thoughts about
GlaxoSmithKline PLC?
Write Note

GlaxoSmithKline PLC
Other Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

GlaxoSmithKline PLC
Other Operating Expenses Peer Comparison

Comparables:
A
AZN
INDV
HIK
AGY
DPH

Competitive Other Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Other Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
G
GlaxoSmithKline PLC
NYSE:GSK
Other Operating Expenses
-ÂŁ262m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
A
AstraZeneca PLC
NASDAQ:AZN
Other Operating Expenses
$10m
CAGR 3-Years
N/A
CAGR 5-Years
-66%
CAGR 10-Years
N/A
Indivior PLC
LSE:INDV
Other Operating Expenses
$2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hikma Pharmaceuticals PLC
LSE:HIK
Other Operating Expenses
-$13m
CAGR 3-Years
25%
CAGR 5-Years
28%
CAGR 10-Years
9%
Allergy Therapeutics PLC
LSE:AGY
Other Operating Expenses
ÂŁ1.3m
CAGR 3-Years
15%
CAGR 5-Years
24%
CAGR 10-Years
N/A
Dechra Pharmaceuticals PLC
LSE:DPH
Other Operating Expenses
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is GlaxoSmithKline PLC's Other Operating Expenses?
Other Operating Expenses
-262m GBP

Based on the financial report for Jun 30, 2024, GlaxoSmithKline PLC's Other Operating Expenses amounts to -262m GBP.

Back to Top